info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Drug Device Combination Companies

Drug-device combination companies are entities that specialize in developing and commercializing products that integrate pharmaceuticals with medical devices. These combinations often provide synergistic benefits, enhancing the therapeutic effectiveness of medications through targeted delivery systems. These companies operate at the intersection of pharmaceuticals and medical technology, leveraging innovation to address complex medical challenges. Their products range from drug-eluting stents and infusion pumps to wearable devices that administer medications. By combining drug formulations with advanced delivery mechanisms, these companies aim to improve treatment outcomes, minimize side effects, and enhance patient compliance. The field represents a dynamic convergence of pharmaceutical and medical device expertise, fostering advancements in personalized medicine and patient-centric healthcare solutions.

Drug Device Combination CompaniesLatest Drug Device Combination Companies Update



  • Oct 2023 The diversified manufacturer, 3M Co., had its shares rise more than 5% because it raised its full-year adjusted profit projection and reported strong quarterly earnings. The company was able to counteract poor demand with price increases and expense reductions. In response to rising labor and raw material costs, 3M increased pricing and reduced staff as the market for consumer electronics declined. Further price increases in the face of growing living expenses may prove difficult, given that American households are deferring large purchases and reducing discretionary spending due to an uncertain economic future. Although the company's efforts to reduce costs allowed it to surpass projections, 3M is confronted with a sluggish market for consumer electronics, particularly in China and Europe.




  • Sep 2023 The latest generation WATCHMAN FLXTM Pro Left Atrial Appendage Closure (LAAC) Device has been approved by the US Food and Drug Administration, according to a statement released by Boston Scientific Corporation. With a polymer coating, visualization markers, and a broader size matrix to treat a wider range of patients, the device is designed to enhance the procedural effectiveness and security of the WATCHMAN technology, which has been shown to minimize stroke risk among individuals with non-valvular atrial fibrillation that require an alternative to oral anticoagulation therapy. Based on the well-established safety and procedural efficacy of the WATCHMAN FLXTM LAAC device—which was approved in July 2020 and has been utilized in approximately 190,000 of the greater than 300,000 WATCHMAN procedures that have been safely done to date—the WATCHMAN FLX Pro device globally.


List of Drug Device Combination Companies in the market

  • 3M

  • Abbott Laboratories

  • AlloSource

  • Biomet Orthopedics Inc

  • Biometrix Medical

  • Biotronik

  • Boston Scientific Corporation

  • R. BARD Inc

  • Cook Critical Care Inc

  • Covidien Ltd

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.